Join to View Full Profile
1411 N Beckley Ave Ste 370Dallas, TX 75203
Phone+1 214-358-2300
Fax+1 214-579-6983
Dr. Fa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kosunarty Fa is a nephrologist in Dallas, TX and is affiliated with multiple hospitals in the area, including Medical City Dallas, Methodist Charlton Medical Center, Methodist Dallas Medical Center, and Baylor University Medical Center. She received her medical degree from University Hamburg, Krankenhaus Eppendorf, Fak Med and has been in practice 27 years. She is experienced in hypertension, general nephrology, transplant nephrology, glomerular disease, and dialysis.
Education & Training
University of Pennsylvania Health SystemFellowship, Nephrology, 2002 - 2004
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1999 - 2002
University Hamburg, Krankenhaus Eppendorf, Fak MedClass of 1990
Certifications & Licensure
TX State Medical License 2005 - 2026
PA State Medical License 2002 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 78 citationsOutcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list.Roy D. Bloom, Gabriel Sayer, Kosunarty Fa, Serban Constantinescu, Peter L. Abt
American Journal of Transplantation. 2005-01-01 - 51 citationsBlood Pressure and the Survival of Renal Allografts from Living DonorsKevin C. Mange, Harold I. Feldman, Marshall M. Joffe, Kosunarty Fa, Roy D. Bloom
Journal of the American Society of Nephrology. 2004-01-01 - 15 citationsBasiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation.R.K Kode, Kosunarty Fa, Shoaib Chowdhury, Karthik Ranganna, Billie Fyfe
Clinical Transplantation. 2003-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
